+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Infertility Services Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6147821
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Infertility Services Market is projected to reach USD 36.60 Billion in 2026. It is expected to continue growing at a CAGR of 8.30%, reaching USD 58.94 Billion by 2032.

Infertility Services: Executive Overview

Infertility services encompass diagnosis, fertility preservation, assisted reproductive technologies, donor programs, and related clinical and laboratory support. Demand is shaped by delayed childbearing, infertility prevalence, changing family-formation preferences, improved clinical awareness, and wider acceptance of fertility care. Access remains uneven because treatment costs, insurance coverage, regulation, geography, and cultural attitudes differ substantially across health systems.

How Demographics, Access, and Regulation Are Reshaping Care

The sector is shifting toward earlier evaluation, personalized treatment pathways, fertility preservation, and more integrated patient support. Clinics and laboratories are placing greater emphasis on standardized protocols, laboratory quality, genetic testing where clinically appropriate, digital patient engagement, and continuity of care. At the same time, regulatory variation, affordability barriers, donor availability, and workforce constraints continue to influence which services patients can obtain and how quickly they can progress through treatment.

Artificial Intelligence Is Improving Clinical and Operational Decisions

Artificial intelligence is being applied to embryo assessment, laboratory workflow support, patient triage, scheduling, documentation, and analysis of clinical records. Its practical value depends on representative training data, independent validation, transparent performance measures, cybersecurity, and clinician oversight. Leaders should treat AI as decision support rather than a substitute for reproductive specialists, while establishing governance for consent, privacy, bias monitoring, explainability, and accountability when recommendations affect treatment decisions.

Regional Insights: Uneven Access Across Six Distinct Care Environments

North America combines advanced clinical capacity with significant affordability and insurance-coverage differences. Latin America is characterized by expanding private-sector provision alongside regulatory and access variation. Europe benefits from established clinical infrastructure, but national rules on funding, donor conception, embryo use, and age eligibility differ. The Middle East presents growing interest in fertility care within diverse legal and cultural frameworks. Africa faces pronounced gaps in specialist availability, laboratory capacity, and affordability. Asia-Pacific includes highly developed systems alongside rapidly expanding services, with cross-border care and regulatory diversity influencing patient pathways.

Group Insights: Economic and Institutional Blocs Shape Service Access

ASEAN markets reflect wide differences in regulation, clinical capacity, and affordability, making regional referral networks and consistent quality standards valuable. BRICS members combine large and diverse patient populations with varied public-health resources, reimbursement structures, and legal frameworks. The European Union benefits from cross-border professional and scientific collaboration, although national implementation remains important. G7 systems generally have strong research and clinical capabilities but continue to address affordability, capacity, and equitable access. GCC countries are investing in advanced healthcare infrastructure while navigating donor, genetic, and family-law considerations. NATO members span differing health systems, yet collaboration on resilience, data protection, and medical workforce continuity remains relevant.

Country Insights: Diverse Policy and Care Pathways

Australia and Canada pair sophisticated clinical services with geographic and coverage challenges. Brazil and Mexico have substantial private-sector activity alongside unequal access and regulatory variation. China and India combine broad patient needs with major differences between urban and rural provision. France, Germany, Italy, Spain, and the United Kingdom operate within mature European clinical environments, but eligibility, public funding, and treatment rules differ by jurisdiction. Japan and South Korea face demographic pressures and are strengthening support for family formation, while affordability and age-related considerations remain important. Russia’s service environment is shaped by domestic regulation, regional disparities, and broader healthcare constraints. In the United States, advanced capabilities coexist with pronounced variation in insurance coverage, employer benefits, state regulation, and household affordability.

Priorities for Leaders: Build Trust, Access, and Clinical Resilience

Industry leaders should develop transparent, patient-centered pathways that connect diagnosis, treatment, preservation, counseling, and follow-up. They should strengthen laboratory quality systems, publish clinically meaningful outcomes with appropriate context, and expand financial-navigation support without compromising informed consent. Partnerships with public providers, employers, insurers, and community organizations can improve referral access and reduce geographic barriers. AI adoption should proceed through controlled validation, human review, cybersecurity safeguards, and routine bias assessment. Workforce development, standardized data practices, continuity planning, and culturally competent communication are essential for sustainable service quality.

Research Methodology: Structured Synthesis of Infertility-Service Evidence

This executive summary uses a structured review approach focused on verified information about infertility diagnosis, assisted reproductive technologies, fertility preservation, donor services, laboratory operations, regulation, access, and digital innovation. Findings are organized across the required regions, country groups, and countries, with emphasis on recurring evidence concerning demographics, healthcare infrastructure, reimbursement, legal frameworks, patient experience, and clinical governance. Interpretations are qualitative and deliberately exclude market estimates, market sizing, market shares, forecasts, and company-specific claims.

Conclusion: Equitable, Evidence-Governed Care Will Define Progress

Infertility services are evolving toward more personalized, digitally supported, and integrated care, but progress will depend on whether innovation is matched by affordability, safety, ethical oversight, and geographic reach. Regional and national differences require adaptable operating models rather than a single global template. Organizations that combine rigorous clinical governance, responsible AI, strong laboratory standards, transparent communication, and partnerships that widen access will be better positioned to improve patient outcomes and trust.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Infertility Services Market, by Treatment Type
7.1. Introduction
7.2. Assisted Hatching
7.3. In Vitro Fertilization
7.3.1. Fresh Embryo Transfer
7.3.2. Frozen Embryo Transfer
7.4. Intracytoplasmic Sperm Injection
7.5. Intrauterine Insemination
7.6. Preimplantation Genetic Testing
7.6.1. Pgt Aneuploidy
7.6.2. Pgt Monogenic
8. Infertility Services Market, by Cycle Type
8.1. Introduction
8.2. Autologous Cycles
8.3. Donor Cycles
8.3.1. Donor Egg Cycles
8.3.2. Donor Sperm Cycles
9. Infertility Services Market, by Payer Type
9.1. Introduction
9.2. Insurance Covered
9.3. Self-Funded
10. Infertility Services Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Fertility Clinics
10.4. Hospitals & Clinics
11. Infertility Services Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Infertility Services Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Infertility Services Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Boston IVF
15.2. Bourn Hall Limited
15.3. CARE Fertility
15.4. CCRM Fertility
15.5. Create Fertility
15.6. Embryolab Fertility Clinic
15.7. FutureLife Group
15.8. Genea Limited
15.9. Institut Marquès
15.10. IVIRMA Global
15.11. Monash IVF Group Limited
15.12. Next Generation Clinic
15.13. Reprofit International
15.14. RMA Network
15.15. Shady Grove Fertility
15.16. Tambre Fertility Clinic
15.17. TFP Fertility
15.18. The Fertility Partnership
15.19. UR Vistahermosa
15.20. Virtus Health Limited
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Infertility Services Market, Years Considered for the Study
FIGURE 2. Global Infertility Services Market, Research Design
FIGURE 3. Global Infertility Services Market, Research Framework
FIGURE 4. Global Infertility Services Market, Data Triangulation
FIGURE 5. Global Infertility Services Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Infertility Services Market Size, by Treatment Type, 2025 vs 2032 (%)
FIGURE 7. Global Infertility Services Market Size, by Treatment Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Infertility Services Market Size, by Cycle Type, 2025 vs 2032 (%)
FIGURE 9. Global Infertility Services Market Size, by Cycle Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Infertility Services Market Size, by Payer Type, 2025 vs 2032 (%)
FIGURE 11. Global Infertility Services Market Size, by Payer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Infertility Services Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Infertility Services Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Infertility Services Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Infertility Services Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Infertility Services Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Infertility Services Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Infertility Services Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Infertility Services Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Infertility Services Market Segmentation & Coverage
TABLE 2. Global Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 3. Global Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 4. Global Assisted Hatching Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Assisted Hatching Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Assisted Hatching Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global In Vitro Fertilization Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global In Vitro Fertilization Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global In Vitro Fertilization Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Fresh Embryo Transfer Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Fresh Embryo Transfer Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Fresh Embryo Transfer Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Frozen Embryo Transfer Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Frozen Embryo Transfer Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Frozen Embryo Transfer Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Intracytoplasmic Sperm Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Intracytoplasmic Sperm Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Intracytoplasmic Sperm Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Intrauterine Insemination Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Intrauterine Insemination Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Intrauterine Insemination Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Preimplantation Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Preimplantation Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Preimplantation Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Pgt Aneuploidy Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Pgt Aneuploidy Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Pgt Aneuploidy Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Pgt Monogenic Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Pgt Monogenic Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Pgt Monogenic Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 32. Global Autologous Cycles Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Autologous Cycles Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Autologous Cycles Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Donor Cycles Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Donor Cycles Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Donor Cycles Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Donor Egg Cycles Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Donor Egg Cycles Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Donor Egg Cycles Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Donor Sperm Cycles Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Donor Sperm Cycles Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Donor Sperm Cycles Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 45. Global Insurance Covered Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Insurance Covered Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Insurance Covered Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Self-Funded Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Self-Funded Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Self-Funded Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 52. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Fertility Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Fertility Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Fertility Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Infertility Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Infertility Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 70. North America Infertility Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. North America Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 72. North America Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 73. North America Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 74. North America Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 75. North America Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 76. North America Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 77. North America Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. Latin America Infertility Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Latin America Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 80. Latin America Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 81. Latin America Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 82. Latin America Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 83. Latin America Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 84. Latin America Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 85. Latin America Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. Europe Infertility Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Europe Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 88. Europe Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 89. Europe Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 90. Europe Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 91. Europe Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 92. Europe Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 93. Europe Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Middle East Infertility Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Middle East Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 96. Middle East Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 97. Middle East Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 98. Middle East Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 99. Middle East Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 100. Middle East Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 101. Middle East Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. Africa Infertility Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Africa Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 104. Africa Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 105. Africa Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 106. Africa Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 107. Africa Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 108. Africa Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 109. Africa Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. Global Infertility Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. ASEAN Infertility Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. ASEAN Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 113. ASEAN Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 114. ASEAN Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 115. ASEAN Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 116. ASEAN Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 117. ASEAN Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 118. ASEAN Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. GCC Infertility Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. GCC Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 121. GCC Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 122. GCC Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 123. GCC Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 124. GCC Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 125. GCC Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 126. GCC Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. European Union Infertility Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. European Union Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 129. European Union Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 130. European Union Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 131. European Union Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 132. European Union Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 133. European Union Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 134. European Union Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. BRICS Infertility Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. BRICS Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 137. BRICS Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 138. BRICS Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 139. BRICS Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 140. BRICS Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 141. BRICS Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 142. BRICS Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. G7 Infertility Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. G7 Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 145. G7 Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 146. G7 Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 147. G7 Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 148. G7 Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 149. G7 Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 150. G7 Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. NATO Infertility Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. NATO Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 153. NATO Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 154. NATO Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 155. NATO Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 156. NATO Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 157. NATO Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 158. NATO Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. Global Infertility Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. United States Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 161. United States Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 162. United States Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 163. United States Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 164. United States Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 165. United States Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 166. United States Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 167. United States Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. Canada Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 169. Canada Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 170. Canada Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 171. Canada Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 172. Canada Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 173. Canada Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 174. Canada Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 175. Canada Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. Mexico Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 177. Mexico Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 178. Mexico Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 179. Mexico Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 180. Mexico Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 181. Mexico Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 182. Mexico Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 183. Mexico Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. Brazil Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 185. Brazil Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 186. Brazil Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 187. Brazil Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 188. Brazil Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 189. Brazil Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 190. Brazil Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 191. Brazil Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. United Kingdom Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 193. United Kingdom Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 194. United Kingdom Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 195. United Kingdom Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 196. United Kingdom Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 197. United Kingdom Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 198. United Kingdom Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 199. United Kingdom Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Germany Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 201. Germany Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 202. Germany Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 203. Germany Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 204. Germany Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 205. Germany Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 206. Germany Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 207. Germany Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. France Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 209. France Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 210. France Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 211. France Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 212. France Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 213. France Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 214. France Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 215. France Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Russia Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 217. Russia Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 218. Russia Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 219. Russia Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 220. Russia Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 221. Russia Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 222. Russia Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 223. Russia Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. Italy Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 225. Italy Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 226. Italy Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 227. Italy Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 228. Italy Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 229. Italy Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 230. Italy Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 231. Italy Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. Spain Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 233. Spain Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 234. Spain Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 235. Spain Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 236. Spain Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 237. Spain Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 238. Spain Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 239. Spain Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. China Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 241. China Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 242. China Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 243. China Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 244. China Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 245. China Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 246. China Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 247. China Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. India Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 249. India Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 250. India Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 251. India Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 252. India Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 253. India Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 254. India Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 255. India Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Japan Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 257. Japan Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 258. Japan Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 259. Japan Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 260. Japan Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 261. Japan Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 262. Japan Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 263. Japan Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 264. Australia Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 265. Australia Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 266. Australia Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 267. Australia Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 268. Australia Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 269. Australia Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 270. Australia Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 271. Australia Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. South Korea Infertility Services Market Size, 2017-2032 (USD Million)
TABLE 273. South Korea Infertility Services Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 274. South Korea Infertility Services Market Size, by In Vitro Fertilization, 2017-2032 (USD Million)
TABLE 275. South Korea Infertility Services Market Size, by Preimplantation Genetic Testing, 2017-2032 (USD Million)
TABLE 276. South Korea Infertility Services Market Size, by Cycle Type, 2017-2032 (USD Million)
TABLE 277. South Korea Infertility Services Market Size, by Donor Cycles, 2017-2032 (USD Million)
TABLE 278. South Korea Infertility Services Market Size, by Payer Type, 2017-2032 (USD Million)
TABLE 279. South Korea Infertility Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 280. Global Infertility Services Market Share, by Key Player, 2025
TABLE 281. Global Infertility Services Market, Key Experts

Companies Mentioned

  • Boston IVF
  • Bourn Hall Limited
  • CARE Fertility
  • CCRM Fertility
  • Create Fertility
  • Embryolab Fertility Clinic
  • FutureLife Group
  • Genea Limited
  • Institut Marquès
  • IVIRMA Global
  • Monash IVF Group Limited
  • Next Generation Clinic
  • Reprofit International
  • RMA Network
  • Shady Grove Fertility
  • Tambre Fertility Clinic
  • TFP Fertility
  • The Fertility Partnership
  • UR Vistahermosa
  • Virtus Health Limited